**Question:** A young female who is a known case of myeloproliferative disorder presents with a 3 day history of progressive abdominal discomfort and ascites. Which of the following is the possible diagnosis?

A. Acute myeloid leukemia (AML)
B. Chronic myelomonocytic leukemia (CMML)
C. Chronic myeloid leukemia (CML)
D. Essential thrombocythemia (ET)

**Correct Answer:** C. Chronic myeloid leukemia (CML)

**Core Concept:**
Chronic myeloid leukemia (CML) is a type of myeloproliferative disorder characterized by the presence of a specific chromosomal abnormality, known as the Philadelphia chromosome. This abnormality is a result of a reciprocal translocation between chromosomes 9 and 22, leading to the fusion of BCR and ABL1 genes. The Philadelphia chromosome produces a constitutively active tyrosine kinase enzyme, BCR-ABL1, which leads to uncontrolled proliferation of myeloid cells, resulting in the clinical manifestations of CML.

**Why the Correct Answer is Right:**
In this case, the patient presents with progressive abdominal discomfort and ascites, which are likely due to the excessive production of white blood cells in the bone marrow, leading to organomegaly and compression of surrounding structures. CML is one of the myeloproliferative disorders, and the Philadelphia chromosome is a hallmark of this condition. Among the given options, CML is the only one associated with the Philadelphia chromosome and the resulting BCR-ABL1 fusion protein.

**Why Each Wrong Option is Incorrect:**
A. Acute myeloid leukemia (AML): AML is a distinct entity characterized by rapid proliferation of immature myeloid cells, often presenting with pancytopenia, bleeding, and infection rather than abdominal symptoms.
B. Chronic myelomonocytic leukemia (CMML): CMML is a myeloproliferative disorder characterized by increased monocytes and a broad clinical spectrum, but it typically presents with constitutional symptoms (fatigue, fever, night sweats) rather than abdominal symptoms.
D. Essential thrombocythemia (ET): ET is a myeloproliferative disorder characterized by increased platelets, often presenting with bleeding, thrombosis, or headaches. ET does not typically present with abdominal symptoms like progressive abdominal discomfort and ascites.

**Clinical Pearl:**
The clinical presentation and laboratory findings of the patient with myeloproliferative disorders can be helpful in narrowing down the diagnosis. However, the presence of Philadelphia chromosome and BCR-ABL1 fusion protein are essential for the correct diagnosis of CML. In this case, the patient's symptoms and laboratory findings are more consistent with a myeloproliferative disorder, but the correct diagnosis cannot be confirmed without the presence of the Philadelphia chromosome and the BCR-ABL1 fusion protein.

**Why the Correct Answer is Right:**
In this case, the correct diagnosis of CML is supported by the patient's clinical presentation of progressive abdominal discomfort and ascites, which are consistent with the myeloproliferative disorders. The Philadelphia chromosome is present in approximately 95% of cases of CML and